Go to deals
Private Equity | Healthcare

TDK Corporation has divested its medical business HTI Medical to GTCR-backed Resonetics

Hutchinson Technology, Inc., a subsidiary of TDK Corporation, has sold its medical business HTI Medical to Resonetics, a portfolio company of GTCR.

HTI Medical manufactures and assembles tight-tolerance metal components principally for medical devices used to seal vessels in minimally invasive and open surgery. The company has proprietary processes to chemically etch blades, create ceramic features on metal substrates and fabricate miniaturized electromechanical sensors for hand-held and robotic surgical instruments.

Resonetics is a pioneer in micro-manufacturing, serving the life sciences industry. The acquisition of HTI Medical will expand its precision manufacturing capabilities. GTCR is a leading private equity firm which has invested more than US$18 billion in over 200 companies.

TDK Corporation, together with its subsidiaries, manufactures and sells electronic components in Japan, Europe, China, Asia, the Americas, and internationally.

One of Oaklins’ teams in the USA served as the exclusive financial advisor to Hutchinson Technology, Inc., a subsidiary of TDK Corporation. The team in Irvine had advised TDK on its prior acquisition of the parent of HTI Medical, Hutchinson Technology, and referred this transaction to the team.

Service
M&A sell-side
Parties
“The team brought valuable capabilities to the sale of our HTI Medical business, including deep experience in the medical device components sector, strong relationships with all of the key acquirers, and expertise in the nuances of corporate divestitures. Their commitment throughout this process drove an outstanding result for our company, our customers and HTI Medical’s management and employees.”

Steve Misuta

President and COO, Hutchinson Technology, Inc.

Talk to the deal team

 Michael S. Goldman

Michael S. Goldman

Managing Director

New York, United States
Oaklins TM Capital
 James  McLaren

James McLaren

Managing Director

New York, United States
Oaklins TM Capital
 Stephen  Perry

Stephen Perry

Managing Director

Irvine, United States
Oaklins Janes Capital
 Jason  Kimball

Jason Kimball

Director

Irvine, United States
Oaklins Janes Capital
 John  Dean

John Dean

Associate Director

Atlanta, United States
Oaklins TM Capital

Related deals

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Private Equity | Healthcare

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital

Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.

Learn more
Argon Corporation has been acquired by Spectra
Private Equity | Aerospace & Defense

Argon Corporation has been acquired by Spectra

The private shareholders of Argon Corporation have sold the company to Spectra Aerospace and Defense, LLC (Spectra), a platform formed by Vance Street Capital.

Learn more
Commercial Tube Processing has been acquired by Nelson Global Products
Private Equity | Industrial Machinery & Components

Commercial Tube Processing has been acquired by Nelson Global Products

Tube Processing Corporation has sold its division Commercial Tube Processing (CTP) to Nelson Global Products Inc.

Learn more